🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 50015M109
- Market Cap
- Mid Cap
- IPO
- 10/3/2018 · $10.00/share
Business: Kodiak Sciences, Inc. is a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases.
Company Contact
- CEO
- Victor Perlroth, M.D.
- CFO
- John A. Borgeson
- Headquarters
- 1200 Page Mill Road, Palo Alto, CA
- Phone
- 650-281-0850
- Investor Relations
- John Borgeson · 650-281-0850 · info@kodiak.com